StockGlow

BeyondSpring Inc. (BYSI)

Develops cancer-fighting drugs combining immunotherapy with chemotherapy in clinical trials

$1.19+0.01%Healthcare
Compare BYSI with
StockGlow Score
8
Bearish
BearishBullish
1 year ago-42.8%

The outlook

BeyondSpring (BYSI) is trading near its 52-week lows, well below both its 50- and 200-day moving averages, signaling a downtrend. Analyst coverage appears thin, and the overall sentiment leans bearish based on current market positioning.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range13% of the way from its 52-week low to high
Market cap
$48.7M
52-wk high
$2.44
52-wk low
$0.99
50-day avg
$1.54
200-day avg
$1.67
Trailing P/E
—

Similar stocks

FULCFulcrum Therapeutics, Inc.$3.72-0.27%VRPXVirpax Pharmaceuticals, Inc.$0.00-75.00%GRTXDGalera Therapeutics, Inc.$15.57+2.10%ATXIAvenue Therapeutics, Inc.$0.30+20.00%IPHAInnate Pharma S.A.$1.68-5.17%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy